Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 116: | Line 116: | ||
****[[Phosphatidylinositol 3-Kinase]] | ****[[Phosphatidylinositol 3-Kinase]] | ||
****[[SRC]] | ****[[SRC]] | ||
| - | ***[[Matt Routh sandbox|MDM2 Bound to p53]] | ||
***[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | ***[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | ||
***Oncogenes | ***Oncogenes | ||
****[[C-Myc]] - Proto-Oncogenic Gene | ****[[C-Myc]] - Proto-Oncogenic Gene | ||
****[[P53]] - Tumor Suppressing Gene | ****[[P53]] - Tumor Suppressing Gene | ||
| + | ****[[Matt Routh sandbox|MDM2 Bound to p53]] | ||
****[[SRC]] - Proto-Oncogenic Tyrosine Kinase Gene | ****[[SRC]] - Proto-Oncogenic Tyrosine Kinase Gene | ||
***[[Ann_Taylor_sandbox_Proteins_in_Cancer|Proteins in Cancer]] | ***[[Ann_Taylor_sandbox_Proteins_in_Cancer|Proteins in Cancer]] | ||
Revision as of 10:47, 1 October 2010
The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
